Aldebaran Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-8,668
Closed -$564K 95
2019
Q1
$564K Sell
8,668
-6,687
-44% -$444K 0.4% 73
2018
Q4
$960K Sell
15,355
-537
-3% -$37.5K 0.73% 50
2018
Q3
$1.23M Sell
15,892
-88
-0.6% -$6.65K 0.8% 47
2018
Q2
$1.13M Sell
15,980
-1,750
-10% -$124K 0.78% 48
2018
Q1
$1.34M Sell
17,730
-125
-0.7% -$9.94K 0.9% 44
2017
Q4
$1.28M Buy
17,855
+600
+3% +$45.6K 0.85% 46
2017
Q3
$1.4M Hold
17,255
0.96% 40
2017
Q2
$1.22M Sell
17,255
-500
-3% -$33.3K 0.89% 44
2017
Q1
$1.21M Buy
17,755
+441
+3% +$31K 0.92% 41
2016
Q4
$1.24M Sell
17,314
-975
-5% -$72.5K 0.98% 37
2016
Q3
$1.45M Buy
18,289
+365
+2% +$29.6K 1.15% 32
2016
Q2
$1.55M Sell
17,924
-50
-0.3% -$4.44K 1.25% 30
2016
Q1
$1.65M Buy
17,974
+60
+0.3% +$5.41K 1.44% 24
2015
Q4
$1.76M Sell
17,914
-425
-2% -$44.2K 1.63% 23
2015
Q3
$1.8M Buy
18,339
+525
+3% +$58.3K 1.7% 21
2015
Q2
$2.09M Sell
17,814
-1,315
-7% -$144K 1.76% 17
2015
Q1
$1.88M Buy
19,129
+200
+1% +$20.3K 1.61% 20
2014
Q4
$1.78M Buy
18,929
+979
+5% +$101K 1.57% 22
2014
Q3
$1.91M Sell
17,950
-1,825
-9% -$179K 1.71% 18
2014
Q2
$1.64M Buy
19,775
+5,700
+40% +$444K 1.29% 28
2014
Q1
$997K Buy
14,075
+2,875
+26% +$225K 0.87% 38
2013
Q4
$841K Buy
+11,200
New +$780K 0.8% 46

Other funds holding GILD

Aldebaran Financial's GILD Position: Q2 2019 in Review

Aldebaran Financial sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 8,668 shares — an estimated $564K sold.

Aldebaran Financial first reported a position in GILD in Q4 2013 and held it in 22 quarters. The position peaked at $2.09M in Q2 2015. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Aldebaran Financial reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • Aldebaran Financial sold 8,668 Gilead Sciences shares in Q2 2019, an estimated $564K.
  • Aldebaran Financial first reported a position in Gilead Sciences in Q4 2013 and held it in 22 quarters.
  • Aldebaran Financial's Gilead Sciences position peaked at $2.09M in Q2 2015.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Aldebaran Financial's 13F filing for Q2 2019, filed 14 Aug 2019.